Up-regulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2

Molecular Pharmacology

Volumn 77, Issue 6, 2010, Pages 987-994

  Lee, Andy C ^a   Murray, Michael ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ARACHIDONIC ACID; BUTYLATED HYDROXYANISOLE; CYTOCHROME P450 2J2; DIMER; EPOXYICOSATRIENOIC ACID; MESSENGER RNA; MUTANT PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR NRF2;

5' UNTRANSLATED REGION; ARTICLE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HOMEOSTASIS; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME; TRANSACTIVATION; UPREGULATION;

ANTIOXIDANTS; BASE SEQUENCE; BUTYLATED HYDROXYANISOLE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; NF-E2-RELATED FACTOR 2; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 77952418586     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.062729     Document Type: Article

References (37)

1. Akhouayri O and St-Arnaud R (2007) Differential mechanisms of transcriptional regulation of the mouse osteocalcin gene by Jun family members. Calcif Tissue Int 80:123-131. (Pubitemid 46294967)
2. Brown PH, Alani R, Preis LH, Szabo E, and Birrer MJ (1993) Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8:877-886. (Pubitemid 23087418)
3. Chen JK, Capdevila J, and Harris RC (2001) Cytochrome P450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 21:6322-6331. (Pubitemid 34263530)
4. Chen JK, Falck JR, Reddy KM, Capdevila J, and Harris RC (1998) Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J Biol Chem 273:29254-29261.
5. Chung FL, Wang M, Carmella SG, and Hecht SS (1986) Effects of butylated hydroxyanisole on the tumorigenicity and metabolism of N-nitrosodimethylamine and N-nitrosopyrrolidine in A/J mice. Cancer Res 46:165-168.
6. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, and Talalay P (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99:11908-11913.
7. Fiala-Beer E, Lee AC, and Murray M (2007) Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1. Int J Biochem Cell Biol 39: 1235-1247.
8. Higgins LG, Kelleher MO, Eggleston IM, Itoh K, Yamamoto M, and Hayes JD (2009) Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol Appl Pharmacol 237:267-280.
9. Huang HC, Nguyen T, and Pickett CB (2000) Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci USA 97:12475-12480.
10. Jaiswal AK (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36:1199-1207.
11. Jeyapaul J and Jaiswal AK (2000) Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 59:1433-1439.
12. Kroetz DL and Zeldin DC (2002) Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 13:273-283.
13. Lee HC, Lu T, Weintraub NL, VanRollins M, Spector AA, and Shibata EF (1999) Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes. J Physiol 519:153-168.
14. Li W, Yu S, Liu T, Kim JH, Blank V, Li H, and Kong AN (2008) Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim Biophys Acta 1783:1847-1856.
15. Marden NY, Fiala-Beer E, Xiang SH, and Murray M (2003) Role of activator protein- 1 in the down-regulation of the human CYP2J2 gene in hypoxia. Biochem J 373:669-680.
16. Marden NY and Murray M (2005) Characterization of a c-Jun-responsive module in the 5′-flank of the human CYP2J2 gene that regulates transactivation. Biochem J 391:631-640.
17. McBride K and Nemer M (1998) The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers. Mol Cell Biol 18:5073-5081.
18. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, and Liao JK (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285:1276-1279.
19. Potente M, Michaelis UR, Fisslthaler B, Busse R, and Fleming I (2002) Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1. J Biol Chem 277:15671-15676.
20. Pozzi A, Macias-Perez I, Abair T, Wei S, Su Y, Zent R, Falck JR, and Capdevila JH (2005) Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9- EET) as potent in vivo angiogenic lipids. J Biol Chem 280:27138-27146.
21. Rooney JW, Hoey T, and Glimcher LH (1995) Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2:473-483.
22. Scarborough PE, Ma J, Qu W, and Zeldin DC (1999) P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 31:205-234.
23. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, and Liao JK (2002) Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids. Circ Res 90:1020-1027.
24. Venugopal R and Jaiswal AK (1998) Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17:3145-3156.
25. Vial E, Perez S, and Castellazzi M (2000) Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors. Oncogene 19:5020-5029.
26. Vinson C, Acharya A, and Taparowsky EJ (2006) Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta 1759:4-12.
27. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, and Talalay P (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101:2040-2045.
28. Waxman DJ (1999) P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 369:11-23.
29. Williams GM and Iatropoulos MJ (1996) Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett 104:49-53.
30. Wu S, Moomaw CR, Tomer KB, Falck JR, and Zeldin DC (1996) Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460-3468.
31. Xie Q, Zhang QY, Zhang Y, Su T, Gu J, Kaminsky LS, and Ding X (2000) Induction of mouse CYP2J by pyrazole in the eye, kidney, liver, lung, olfactory mucosa, and small intestine, but not in the heart. Drug Metab Dispos 28:1311-1316.
32. Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, and Zeldin DC (2001) Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60:310-320.
33. Yoon HY, Kang NI, Lee HK, Jang KY, Park JW, and Park BH (2008) Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol 75:2214-2223.
34. Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, and Kong AN (2000) Activation of mitogen-activated protein kinase pathways induces antioxidant response element- mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 275:39907-39913.
35. Yu R, Tan TH, and Kong AN (1997) Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J Biol Chem 272:28962-28970.
36. Yuan X, Xu C, Pan Z, Keum YS, Kim JH, Shen G, Yu S, Oo KT, Ma J, and Kong AN (2006) Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol Carcinog 45:841-850.
37. Zeldin DC, Moomaw CR, Jesse N, Tomer KB, Beetham J, Hammock BD, and Wu S (1996) Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330:87-96.